Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-26-260329
Filing Date
2026-06-08
Accepted
2026-06-05 21:28:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d117004ds3a.htm S-3/A 297743
2 EX-23.1 d117004dex231.htm EX-23.1 1333
3 GRAPHIC g117004g00g00.jpg GRAPHIC 34502
  Complete submission text file 0001193125-26-260329.txt   341561
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-296425 | Film No.: 261070875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)